
SHL Telemedicine (NASDAQ: SHLT) (SIX: SHLTN), a pioneer in telemedicine solutions, is taking a significant step in the U.S. healthcare market.
With the soft launch of its SmartHeartmembership program, the company is not just expanding its service portfolio, but also strategically positioning itself in the burgeoning direct-to-consumer (D2C) healthcare sector. This move signals a deepened commitment to innovation and understanding the evolving needs of healthcare consumers, especially in the domain of at-home cardiac care.